Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Profiles of genomic instability in high-grade serous ovarian cancer (HGSC) predict treatment outcome

ABSTRACT: Profiling of loss of heterozygosity (LOH) in HGSC, subcrouping HGSC by LOH-based clustering and comparing to the LOH profiles of triple-negative breast cancer [previously submitted; GSE19594]. Study for the correlation of LOH burdern and LOH-based subgroups to clinical response to platinum-based chemotherapy in patients suffered from HGSC. SNP data (Affymetrix GenChip 250K SNP Nsp) from 47 high grade serous ovarian cancer were generated and used for LOH and copy number analysis, LOH-based hierarchical clustering to subclassify HGSC, and comparison to the chromosomal alterations in high grade brest cancer. The associstion between LOH-based subgroups and LOH burden and clinical resposne to platinum-based chemotherapy was investigated. The results were validated in two independent public opening datasets.

ORGANISM(S): Homo sapiens

SUBMITTER: Zhigang Wang 

PROVIDER: E-GEOD-39130 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Json Xml
altmetric image

Publications

<h4>Purpose</h4>High-grade serous cancer (HGSC) is the most common cancer of the ovary and is characterized by chromosomal instability. Defects in homologous recombination repair (HRR) are associated with genomic instability in HGSC, and are exploited by therapy targeting DNA repair. Defective HRR causes uniparental deletions and loss of heterozygosity (LOH). Our purpose is to profile LOH in HGSC and correlate our findings to clinical outcome, and compare HGSC and high-grade breast cancers.<h4>E  ...[more]

Similar Datasets

Genomics Profiles of genomic instability in high-grade serous ovarian cancer (HGSC) predict treatment outcome
2012-11-06 | GSE39130 | GEO
Proteomics A combination of molecular and clinical parameters provides a new strategy for high-grade serous ovarian cancer patient management
2023-03-11 | PXD035084 | Pride
Transcriptomics Whole genome characterisation of chemoresistant ovarian cancer [NanoString miRNA]
2015-05-19 | E-GEOD-65819 | biostudies-arrayexpress
Methylation profiling Whole genome characterisation of chemoresistant ovarian cancer [Illumina_450K_Methylation]
2015-05-19 | GSE65820 | GEO
Genomics Whole genome characterisation of chemoresistant ovarian cancer [NanoString miRNA]
2015-05-19 | GSE65819 | GEO
Genomics Whole genome characterisation of chemoresistant ovarian cancer [Illumina_Omini 2.5-8_SNP]
2015-05-19 | GSE61568 | GEO
Genomics Whole genome characterisation of chemoresistant ovarian cancer
2015-05-19 | GSE65821 | GEO
Transcriptomics Transcriptomes of tumour-associated macrophages from high grade serous ovarian cancer pre- and post-platinum-based neoadjuvant chemotherapy.
2021-04-20 | GSE158739 | GEO
Transcriptomics Generation of low passage high grade serous ovarian cancer cell lines from primary tumors
2015-08-01 | E-GEOD-70073 | biostudies-arrayexpress
Transcriptomics Whole genome characterisation of chemoresistant ovarian cancer [Illumina_450K_Methylation]
2015-05-19 | E-GEOD-65820 | biostudies-arrayexpress